Grana, R., Benowitz, N. & Glantz, S. A. ECs: A scientific review. Circulation 129, 1972–1986 (2014).
Liu, Y. et al. Smoking duration, respiratory symptoms, and COPD in adults aged ≥ 45 years with a smoking history. Int. J. Chron. Obstruct. Pulmon. Dis. 21(10), 1409–1416. doi.org/10.2147/COPD.S82259 (2015).
Dhariwal, J. et al. Smoking cessation in COPD causes a transient improvement in spirometry and decreases micronodules on high-resolution CT imaging. Chest 145(5), 1006–1015. doi.org/10.1378/chest.13-2220 (2014).
Zhao, Z. et al. E-cigarette use among adults in China: Findings from repeated cross-sectional surveys in 2015–16 and 2018–19. Lancet Public Health 5(12), e639–e649. doi.org/10.1016/S2468-2667(20)30145-6 (2020).
Xiao, L. et al. Awareness and prevalence of EC use among Chinese adults: Policy implications. Tob. Control 31, 498–504. doi.org/10.1136/tobaccocontrol-2020-056114 (2020).
Xiao, L., Parascandola, M., Wang, C. & Jiang, Y. Perception and current use of ECs among youth in China. Nicotine Tob. Res. Off. J. Soc. Res. Nicotine Tob. 21, 1401–1407 (2019).
Chinese Center for Disease Control and Prevention. Tobacco control: 2019 China’s national youth tobacco survey. 2020. www.chinacdc.cn/jkzt/sthd_3844/slhd_12885/202005/t20200531_216942.html.
Bhatta, D. N. & Glantz, S. A. Association of EC use with respiratory disease among adults: A longitudinal analysis. Am. J. Prev. Med. 58, 182–190. doi.org/10.1016/j.amepre.2019.07.028 (2020).
Kalininskiy, A. et al. E-cigarette, or vaping, product use associated lung injury (EVALI): Case series and diagnostic approach. Lancet Respir. Med. 7(12), 1017–1026. doi.org/10.1016/S2213-2600(19)30415-1 (2019).
Hartnett, K. P. et al. Syndromic surveillance for EC, or vaping, product use-associated lung injury. N. Engl. J. Med. 382, 766–772. doi.org/10.1056/NEJMsr1915313 (2020).
Fang, L. et al. Chronic obstructive pulmonary disease in China: A nationwide prevalence study. Lancet Respir. Med. 6(6), 421–430. doi.org/10.1016/S2213-2600(18)30103-6 (2018).
Tackett, A. P. et al. Evaluation of respiratory symptoms among youth e-cigarette users. JAMA Netw. Open 3(10), e2020671. doi.org/10.1001/jamanetworkopen.2020.20671 (2020).
Varella, M. H. et al. E-cigarette use and respiratory symptoms in residents of the United States: A BRFSS report. PLoS ONE 17(12), e0269760. doi.org/10.1371/journal.pone.0269760 (2022).
Osei, A. D. et al. Association between EC use and chronic obstructive pulmonary disease by smoking status: Behavioral risk factor surveillance system 2016 and 2017. Am. J. Prev. Med. 58, 336–342 (2020).
Xie, Z., Ossip, D. J., Rahman, I. & Li, D. Use of electronic cigarettes and self-reported chronic obstructive pulmonary disease diagnosis in adults. Nicotine Tob. Res. 22(7), 1155–1161. doi.org/10.1093/ntr/ntz234 (2020).
Physical Examination Standards for Civil Servants of China. www.chinagwy.org.
McConnell, R. et al. Electronic cigarette use and respiratory symptoms in adolescents. Am. J. Respir. Crit. Care Med. 195(8), 1043–1049. doi.org/10.1164/rccm.201604-0804OC (2017).
Wang, M. P., Ho, S. Y., Leung, L. T. & Lam, T. H. Electronic cigarette use and respiratory symptoms in Chinese adolescents in Hong Kong. JAMA Pediatr. 170(1), 89–91. doi.org/10.1001/jamapediatrics.2015.3024 (2016).
Varella, M. H. et al. E-cigarette use and respiratory symptoms in residents of the United States: A BRFSS report. PLoS ONE 17(12), e0269760. doi.org/10.1371/journal.pone.0269760 (2022).
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2017 report) (2007).
Marcoa, A. R. et al. Classification of chronic obstructive pulmonary disease (COPD) according to the new global initiative for chronic obstructive lung disease (GOLD). J. Chron. Obstruct. Pulmon. Dis. 15(1), 21–26 (2017).
Ash, J. S. et al. Standard practices for computerized clinical decision support in community hospitals: A national survey. J. Am. Med. Inform. Assoc. 19(6), 980–987. doi.org/10.1136/amiajnl-2011-000705 (2012).
Zhou, B. F. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed. Environ. Sci. 15(1), 83–96 (2002).
Kim, S. J. et al. Age-related annual decline of lung function in patients with COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 30(11), 51–60. doi.org/10.2147/COPD.S95028 (2015).
Ntritsos, G. et al. Gender-specific estimates of COPD prevalence: A systematic review and meta-analysis. Int. J. Chron. Obstruct. Pulmon. Dis. 10(13), 1507–1514. doi.org/10.2147/COPD.S146390 (2018).
Zhai, M. et al. DALY trend and predictive analysis of COPD in China and its provinces: Findings from the global burden of disease study. Front. Public Health 23(10), 1046773. doi.org/10.3389/fpubh.2022.1046773 (2022).
Tabak, C. et al. Alcohol consumption in relation to 20-year COPD mortality and pulmonary function in middle-aged men from three European countries. Epidemiology 12(2), 239–245. doi.org/10.1097/00001648-200103000-00018 (2001).
Zhang, L. et al. The incidence and prevalence of pulmonary hypertension in the COPD population: A systematic review and meta-analysis. Int. J. Chron. Obstruct. Pulmon. Dis. 10(17), 1365–1379. doi.org/10.2147/COPD.S359873 (2022).
Ekroos, K. et al. Lipid-based biomarkers for CVD, COPD, and aging—A translational perspective. Prog. Lipid Res. 78, 101030. doi.org/10.1016/j.plipres.2020.101030 (2020).
Bowler, R. P. et al. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes. Am. J. Respir. Crit. Care Med. 191(3), 275–284. doi.org/10.1164/rccm.201410-1771OC (2015).
Kisiel, M. A. et al. Association between abdominal and general obesity and respiratory symptoms, asthma and COPD. Results from the RHINE study. Respir. Med. 211, 107213. doi.org/10.1016/j.rmed.2023.107213 (2023).
Harrell, Jr. F. E. Regression Modeling Strategies 2nd edn. (Springer, 2015).
Xiao, L. et al. Awareness and prevalence of e-cigarette use among Chinese adults: Policy implications. Tob. Control 31(4), 498–504. doi.org/10.1136/tobaccocontrol-2020-056114 (2022).
Polosa, R. et al. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes. Respir. Res. 17(1), 166. doi.org/10.1186/s12931-016-0481-x (2016).
Hartnett, K. P. et al. Syndromic surveillance for e-cigarette, or vaping, product use-associated lung injury. N. Engl. J. Med. 382(8), 766–772. doi.org/10.1056/NEJMsr1915313 (2020).
Adkins, S. H. et al. Lung injury clinical task force and the lung injury epidemiology/surveillance task force. Demographics, substance use behaviors, and clinical characteristics of adolescents with e-cigarette, or vaping, product use-associated lung injury (EVALI) in the United States in 2019. JAMA Pediatr. 174(7), e200756. doi.org/10.1001/jamapediatrics.2020.0756 (2020).
Li, D. & Xie, Z. Cross-sectional association of lifetime electronic cigarette use with wheezing and related respiratory symptoms in U.S. adults. Nicotine Tob. Res. 22(Suppl 1), S85–S92. doi.org/10.1093/ntr/ntaa195 (2020).
Wills, T. A., Pagano, I., Williams, R. J. & Tam, E. K. E-cigarette use and respiratory disorder in an adult sample. Drug Alcohol Depend. 1(194), 363–370. doi.org/10.1016/j.drugalcdep.2018.10.004 (2019).
Pettigrew, S. et al. E-cigarette-related beliefs, behaviors, and policy support among young people in China. Tob. Induc. Dis. 23(21), 09. doi.org/10.18332/tid/156836 (2023).
McConnell, R. et al. Electronic cigarette use and respiratory symptoms in adolescents. Am. J. Respir. Crit. Care Med. 195(8), 1043–1049. doi.org/10.1164/rccm.201604-0804OC (2017).
Chaffee, B. W. et al. E-cigarette use and adverse respiratory symptoms among adolescents and young adults in the United States. Prev. Med. 153, 106766. doi.org/10.1016/j.ypmed.2021.106766 (2021).
Wills, T. A., Soneji, S. S., Choi, K., Jaspers, I. & Tam, E. K. E-cigarette use and respiratory disorders: An integrative review of converging evidence from epidemiological and laboratory studies. Eur. Respir. J. 57(1), 1901815. doi.org/10.1183/13993003.01815-2019 (2021).
Bircan, E., Bezirhan, U., Porter, A., Fagan, P. & Orloff, M. S. Electronic cigarette use and its association with asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome among never cigarette smokers. Tob Induc Dis. 21(19), 75. doi.org/10.18332/tid/142579 (2021).
Bhatta, D. N. & Glantz, S. A. Association of E-cigarette use with respiratory disease among adults: A longitudinal analysis. Am. J. Prev. Med. 58(2), 182–190. doi.org/10.1016/j.amepre.2019.07.028 (2020).
Wieslander, G., Norback, D. & Lindgren, T. Experimental exposure to propylene glycol mist in aviation emergency training: Acute ocular and respiratory effects. Occup. Environ. Med. 58(10), 649–655. doi.org/10.1136/oem.58.10.649 (2001).
Farsalinos, K. E., Kistler, K. A., Gillman, G. & Voudris, V. Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. Nicotine Tob. Res. 17(2), 168–174. doi.org/10.1093/ntr/ntu176 (2015).
Olmedo, P. et al. Metal concentrations in e-cigarette liquid and aerosol samples: The contribution of metallic coils. Environ. Health Perspect. 126(2), 027010. doi.org/10.1289/ehp2175 (2018).
Omaiye, E. E. et al. High-nicotine electronic cigarette products: Toxicity of JUUL fluids and aerosols correlates strongly with nicotine and some flavor chemical concentrations. Chem. Res. Toxicol 32, 1058–1069 (2019).
Shampa, C. et al. Acute exposure to e-cigarettes causes inflammation and pulmonary endothelial oxidative stress in nonsmoking, healthy young subjects. Am. J. Physiol. Lung Cell Mol. Physiol. 317, L155–L166 (2019).
Gilpin, D. F. et al. Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens. Respir. Res. 20, 267 (2019).
Garcia-Arcos, I. et al. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax 71, 1119–1129 (2016).
Yu, V. et al. Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines. Oral Oncol. 52, 58–65 (2016).
World Health Organization. Electronic Nicotine Delivery Systems Report (FCTCCOP/6/10). In Conference of the Parties to the WHO Framework Convention on Tobacco Control (2014).
Jamal, A. et al. Tobacco use among middle and high school students—United States, 2011–2016. MMWR Morb. Mortal. Wkly. Rep. 66(23), 597–603. doi.org/10.15585/mmwr.mm6623a1.Erratum.In:MMWRMorbMortalWklyRep.2017Jul21;66(28):765 (2017).
Rose, A., Filion, K. B., Eisenberg, M. J. & Franck, C. Electronic cigarettes: A comparison of national regulatory approaches. Can. J. Public Health. 106(6), e450–e453. doi.org/10.17269/cjph.106.5043 (2015).
Douglas, H., Hall, W. & Gartner, C. E-cigarettes and the law in Australia. Aust. Fam. Physician 44(6), 415–418 (2015).
Czoli, C. D., Fong, G. T., Goniewicz, M. L. & Hammond, D. Biomarkers of exposure among “dual users” of tobacco cigarettes and electronic cigarettes in Canada. Nicotine Tob. Res. 21(9), 1259–1266. doi.org/10.1093/ntr/nty174 (2019).
